drugset / Trial / NCT00299091
Modification of Doses of Efavirenz According to Its Blood Concentration in HIV Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a study on the utility of the modification of doses of efavirenz guided by its plasma concentration (therapeutic drug monitoring) in HIV-infected patients initiating treatment with Sustiva.
Timeline
- Start
- 2006-09
- Primary completion
- 2008-10
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Efavirenz | Other / unclassified | 200 mg | — |
| Subject | Efavirenz | Other / unclassified | 600 mg | — |